RxDoctor Payments DataLook up a doctor →

Brenda McFarlin, APRN

Adult Health · Lebanon, TNNPI 1699705855

Payments from drug & device makers

$10,939in general payments, 2019–2025

Across 682 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$2K
  • AstraZeneca$769
  • Amgen$763
  • Corcept Therapeutics$654
  • Lilly USA, LLC$474
  • plus $4K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk107$1,979
AbbVie(2 entities)171$1,901
AstraZeneca(2 entities)42$769
Amgen54$763
Corcept Therapeutics27$654
Lilly USA, LLC32$474
Mannkind Corporation18$276
Boehringer Ingelheim16$252
Takeda Pharmaceuticals U.S.A., Inc.18$230
Abbott17$222
Xeris Pharmaceuticals, Inc.10$188
Medtronic7$162
Antares Pharma, Inc.9$160
Novartis9$157
Pfizer9$154
Otsuka America Pharmaceutical, Inc.8$153
Astellas Pharma US Inc7$146
Bayer7$136
Biohaven Pharmaceutical Holding Company Ltd.6$119
Insulet Corporation6$119
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$112
GSK6$110
BETA Bionics, Inc.2$110
Azurity Pharmaceuticals, Inc.6$108
Cequr Corporation3$96
Sanofi-aventis U.S. LLC5$90
Esperion Therapeutics, Inc.4$89
Arbor Pharmaceuticals, Inc.5$84
Sumitomo Pharma America, Inc.4$76
Dexcom, Inc.4$74
Sequel Med Tech, LLC3$73
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$65
Lundbeck LLC3$59
Nestle Healthcare Nutrition Inc.3$53
Amarin Pharma, Inc.3$49
Jazz Pharmaceuticals Inc.3$49
Zealand Pharma US, Inc.2$48
Axsome Therapeutics, Inc.2$43
Biohaven Pharmaceuticals, Inc.3$43
Teva Pharmaceuticals USA, Inc.3$41
Alkermes, Inc.2$40
Exact Sciences2$37
Shield Therapeutics Inc2$37
Radius Health, Inc.2$34
Corium, LLC3$32
Clarus Therapeutics Inc.2$28
Kowa Pharmaceuticals America, Inc.2$28
Boston Scientific1$27
Nevro Corp.1$27
LEO Pharma Inc.1$19
Ascensia Diabetes Care US Inc.1$18
Madrigal Pharmaceuticals1$17
Amphastar Pharmaceuticals, Inc.1$17
Adlon Therapeutics L.p.1$17
Ultragenyx Pharmaceutical Inc.1$16
Tandem Diabetes Care, Inc.1$16
IBSA Pharma Inc.1$16
Philips North America LLC1$13
Merck1$12

How this compares

$10,939 in reported general payments places this provider in the 95th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$61,598
Medicare patients
249
Services billed
3,164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Lebanon

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →